Esophageal Cancer
Showing NaN - NaN of 39
Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)
Not yet recruiting
- Esophageal Cancer
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023
Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)
Recruiting
- Esophageal Cancer
- Utidelone and anlotinib
-
Weihui, Henan, China
- +2 more
May 10, 2023
Esophageal Cancer Trial in Worldwide (Atezolizumab, Tiragolumab, Paclitaxel)
Active, not recruiting
- Esophageal Cancer
- Atezolizumab
- +5 more
-
Anyang City, China
- +68 more
Jan 20, 2023
Esophageal Cancer Trial in Beijing (3DCRT)
Recruiting
- Esophageal Cancer
- 3DCRT
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/Nationa
Sep 13, 2022
Nutrition Intervention Trials in Linxian Follow-up Study
Enrolling by invitation
- Esophageal Cancer
- Gastric Cancer
-
Beijing, ChinaCancer Institute and hospital, Chinese Academy of Medical Scienc
Aug 24, 2022
Esophageal Cancer, Perioperative Analgesia, NSAIDs Trial in Beijing (Preemptive flurbiprofen axetil, Postoperative flurbiprofen
Not yet recruiting
- Esophageal Cancer
- +4 more
- Preemptive flurbiprofen axetil
- +2 more
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Aug 15, 2022
Adjuvant Radiotherapy for pT1b Esophageal Cancer After
Completed
- Esophageal Cancer
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Aug 10, 2022
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Cancer
- Adjuvant Radiotherapy
-
Beijing, Chaoyang, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Jul 13, 2022
Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)
Recruiting
- Gastric Cancer
- +2 more
- neoantigen tumor vaccine with or without PD-1/L1
-
Beijing, Beijing, ChinaPLA General Hospital
Jan 27, 2022
Esophageal Cancer Trial in Beijing (AN0025)
Not yet recruiting
- Esophageal Cancer
-
Beijing, ChinaChinese PLA General Hospital
Jan 11, 2022
Esophageal Cancer, Chemoradiotherapy, Nimotuzumab Trial in Beijing (Radiotherapy, Nimotuzumab, S-1)
Recruiting
- Esophageal Cancer
- +3 more
- Radiotherapy
- +2 more
-
Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/Nationa
Oct 21, 2021
Esophageal Cancer, Chemoradiotherapy, Albumin-bound Paxlitaxel Trial in Beijing (Radiotherapy, Albumin-Bound Paclitaxel,
Recruiting
- Esophageal Cancer
- +3 more
- Radiotherapy
- +2 more
-
Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/Nationa
Aug 16, 2021
Esophageal Cancer, Chemo Effect, Chemoradiation Trial in Beijing (drug, radiation, procedure)
Recruiting
- Esophageal Cancer
- +6 more
- Platinum based chemotherapy
- +6 more
-
Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/Nationa
Mar 26, 2021
Venous Thromboembolism in Patients Undergoing Major Esophageal
Completed
- Venous Thromboembolism
- +2 more
-
Ann Arbor, Michigan
- +8 more
Feb 23, 2021
Esophageal Cancer Trial in Beijing (Nimotuzumab)
Completed
- Esophageal Cancer
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Feb 2, 2021
Radiotherapy in Lung Cancer and Esophageal Cancer
Recruiting
- Lung Cancer
- Esophageal Cancer
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Hospital, Chinese Acade
Jan 29, 2021
Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian,
Completed
- Esophageal Cancer
-
Beijing, ChinaChinese Academy of Medical Sciences
Dec 10, 2020
Esophageal Cancer Trial in Beijing (Camrelizumab)
Not yet recruiting
- Esophageal Cancer
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Nov 1, 2020
Esophageal Tumors, Esophageal Cancer Trial in Beijing (Adjuvant Chemoradiation, Adjuvant Radiation, Paclitaxel)
Active, not recruiting
- Esophageal Neoplasms
- Esophageal Cancer
- Adjuvant Chemoradiation
- +3 more
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Apr 2, 2020
Esophageal Cancer Trial in Beijing (High-dose, Standard-dose)
Unknown status
- Esophageal Cancer
- High-dose
- Standard-dose
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 7, 2019
PET in Guiding Cervical Lymphadenectomy
Unknown status
- Esophageal Cancer
- positron emission tomography
-
Beijing, Beijing, China
- +3 more
Mar 21, 2019